stars 1 stars 2 stars 3

We believe that clinical adoption of psychedelic therapies represents an opportunity to reduce human suffering on an unprecedented scale. The Psychedelic Action Task Force is a clinician- and scientist-led coalition working to redress the UK mental health crisis and provide solutions to its severe social and economic repercussions, namely, through the democratisation of access to psychedelic treatments in respect of which there is sufficient evidence of both safety and efficacy. Founded by Prof. David Nutt and Alex Adams, Psychedelic Action will be advocating for evidence-based drug policy reform, conducting a revaluation of current clinical paradigms, and facilitating the integration of psychedelic therapy into the UK healthcare system, including the training of clinicians and therapists. Executive Committee: Prof. David Nutt, Alex Adams, Dr. Leyla Hussein OBE, Mabel Evans

Website https://www.psychedelicaction.org
Employees 4 (1 on RocketReach)
Founded 2024
Industry Mental Health Care

Psychedelic Action Task Force Questions

1 people are employed at Psychedelic Action Task Force.

Top Psychedelic Action Task Force Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users